中国当代医药
中國噹代醫藥
중국당대의약
PERSON
2014年
17期
4-7
,共4页
陈国栋%文武%贺军%丁成明%黄秋林%贺更生
陳國棟%文武%賀軍%丁成明%黃鞦林%賀更生
진국동%문무%하군%정성명%황추림%하경생
miRNA%miR-331-3p%肝细胞癌%临床病理特征
miRNA%miR-331-3p%肝細胞癌%臨床病理特徵
miRNA%miR-331-3p%간세포암%림상병리특정
miRNA%miR-331-3p%Hepatocellular carcinoma%Clinical pathological features
目的:运用实时荧光定量PCR(qRT-PCR)技术检测miR-331-3p在肝癌细胞株和肝癌组织中的表达,探讨其在肝癌中表达的临床意义及潜在临床价值。方法采用基于2-△△Ct的qRT-PCR检测miR-331-3p在正常肝细胞株(HL-7702)、不同侵袭转移能力的肝癌细胞株(HepG2、MHCC97-H、HCCLM3)的表达,同时收集5例正常肝组织、30例肝癌组织及癌旁组织,进行定量分析,并分析miR-331-3p与肝癌患者临床病理特征的关系。结果与正常肝细胞株相比,miR-331-3p在肝癌细胞株中表达下调,且随着肝癌细胞株侵袭转移程度增加,其表达下调越明显(P<0.05);与正常肝组织相比,肝癌组织中miR-331-3p有不同程度的表达下调(P<0.05),且与肝癌患者肿瘤多发结节(P=0.036)、低分化程度(P=0.035)以及伴有静脉浸润(P=0.016)等临床病理特征相关。结论 miR-331-3p在肝癌的发生、发展过程可能发挥重要作用,miR-331-3p有望成为肝癌新的生物标志物或预后因子。
目的:運用實時熒光定量PCR(qRT-PCR)技術檢測miR-331-3p在肝癌細胞株和肝癌組織中的錶達,探討其在肝癌中錶達的臨床意義及潛在臨床價值。方法採用基于2-△△Ct的qRT-PCR檢測miR-331-3p在正常肝細胞株(HL-7702)、不同侵襲轉移能力的肝癌細胞株(HepG2、MHCC97-H、HCCLM3)的錶達,同時收集5例正常肝組織、30例肝癌組織及癌徬組織,進行定量分析,併分析miR-331-3p與肝癌患者臨床病理特徵的關繫。結果與正常肝細胞株相比,miR-331-3p在肝癌細胞株中錶達下調,且隨著肝癌細胞株侵襲轉移程度增加,其錶達下調越明顯(P<0.05);與正常肝組織相比,肝癌組織中miR-331-3p有不同程度的錶達下調(P<0.05),且與肝癌患者腫瘤多髮結節(P=0.036)、低分化程度(P=0.035)以及伴有靜脈浸潤(P=0.016)等臨床病理特徵相關。結論 miR-331-3p在肝癌的髮生、髮展過程可能髮揮重要作用,miR-331-3p有望成為肝癌新的生物標誌物或預後因子。
목적:운용실시형광정량PCR(qRT-PCR)기술검측miR-331-3p재간암세포주화간암조직중적표체,탐토기재간암중표체적림상의의급잠재림상개치。방법채용기우2-△△Ct적qRT-PCR검측miR-331-3p재정상간세포주(HL-7702)、불동침습전이능력적간암세포주(HepG2、MHCC97-H、HCCLM3)적표체,동시수집5례정상간조직、30례간암조직급암방조직,진행정량분석,병분석miR-331-3p여간암환자림상병리특정적관계。결과여정상간세포주상비,miR-331-3p재간암세포주중표체하조,차수착간암세포주침습전이정도증가,기표체하조월명현(P<0.05);여정상간조직상비,간암조직중miR-331-3p유불동정도적표체하조(P<0.05),차여간암환자종류다발결절(P=0.036)、저분화정도(P=0.035)이급반유정맥침윤(P=0.016)등림상병리특정상관。결론 miR-331-3p재간암적발생、발전과정가능발휘중요작용,miR-331-3p유망성위간암신적생물표지물혹예후인자。
Objective To detect the expression of miR-331-3p in hepatocellular carcinoma (HCC) by quantificational real-time polymerase chain reaction (qRT-PCR) and investigate the significance and potential clinical value of miR-331-3p in HCC. Methods 2-△△Ct method was used for qRT-PCR of the expression pattern of miR-331-3p in normal human liv-er cell line HL-7702 and different invasion and metastasis of HCC cell lines (HepG2,MHCC97-H,HCCLM3),mean-while,5 normal liver tissues,30 HCC and adjacent tissues were selected,and the relationship between the expression of miR-331-3p and the clinicopathological characteristics of HCC was analyzed. Results Compared with normal liver cell line,hepatocellular carcinoma cell lines showed miR-331-3p down-regulation,and with the increase of the degree of invasion and metastasis,the more obvious its down-regulation (P<0.05).Compared with normal liver tissues,the HCC tis sues showed significant miR-331-3p down-regulation (P<0.05),and it was related to multiple tumor nodules (P=0.036),low differentiation (P=0.035),and venous invasion (P=0.016). Conclusion In the process of the occurrence and development of HCC,miR-331-3p may play an important role,it is expected to become the new biomarker or prognostic factor of HCC.